Pharmacovigilance study of the association between dipeptidyl peptidase–4 inhibitors and angioedema using the FDA Adverse Event Reporting System (FAERS)

Dipeptidyl peptidase-4 (DPP-4) plays a minor role in degrading vasoactive peptides that cause angioedema when angiotensin-converting enzyme (ACE) is present and fully functional. This study investigated the association between DPP-4 inhibitors (DPP-4Is) and angioedema, including cases where the conc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohyama, Katsuhiro, Shindo, Junichiro, Takahashi, Tomohiro, Takeuchi, Hironori, Hori, Yusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338932/
https://www.ncbi.nlm.nih.gov/pubmed/35907939
http://dx.doi.org/10.1038/s41598-022-17366-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338932/
https://www.ncbi.nlm.nih.gov/pubmed/35907939
http://dx.doi.org/10.1038/s41598-022-17366-x

Ejemplares similares